Clin2
NCT04987086Possibly a fitRecruiting

68Ga PSMA PET-CT for kidney cancer spread

Renal CancerMetastasesPSMA PET

Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study checks whether a special PET-CT scan using 68Ga PSMA can better find where renal cell carcinoma has spread. It may help doctors plan the right next steps by confirming suspected metastases on CT.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years to 90 years
Study type
Interventional

Who can take part

  • You have renal cell carcinoma that is stage III or IV (by the AJCC staging system).
  • Your contrast CT scan showed suspicious areas that could be metastases (spread).
  • You are able to lie flat for the PET-CT scan.
  • You do not have known problems with veins (peripheral or central) that would interfere with scanning.
  • Your kidney function is adequate (no major kidney impairment or ongoing hemodialysis).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06428708Recruiting· Early Phase 1
PSMA PET scan for metastatic kidney cancer

This trial uses a special PET scan called PSMA to see if it can better detect kidney cancer that has spread. It may help find tumors that other scans miss.

London, Ontario
NCT06769893Recruiting
New PET scan for kidney cancer staging and monitoring

This study tests a new type of PET scan that uses a tracer called 68Ga-RCCB6 to see kidney cancer more clearly. It compares this scan to another PET scan (68Ga-PSMA) to help doctors stage the cancer, check treatment response, and detect any return of the disease.

Xi'an, China, Shaanxi
NCT07301827Recruiting
New PET imaging for kidney cancer diagnosis

This study tests a new kind of PET scan that might better detect kidney cancer. It involves an injection of a special imaging agent and a scan to see if the cancer shows up clearly.

Wuhan, Hubei
NCT05228106Recruiting
PSMA scan using 68Ga-PSMA-617 PET/CT

This study looks at a PSMA-targeted PET/CT scan using 68Ga-PSMA-617 for tumors that show a specific marker (PSMA). It’s meant to help confirm or evaluate suspected or known PSMA-expressing tumors in real-life clinical practice.

Sherbrooke, Quebec
NCT07144748Recruiting
New PET/CT scan for finding cancer

This study uses a special PET/CT scan (called 68Ga-NYM096) to see if it can help find different types of cancer. The scan may help doctors get clearer pictures of where cancer is in your body.

Beijing
NCT06835244Enrolling by invitation
Study of PSMA PET/CT scans for non-prostate cancers

This study looks at how well a special scan (PSMA PET/CT) works for people with cancers other than prostate cancer. If your doctor already scheduled this scan for your care, you may be able to help researchers learn more about its accuracy.

Bologna

Hear when a new Renal Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.